Skip to main content
Top

Clinical & Experimental Metastasis

Issue 2/2002

Content (11 Articles)

Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells

Andrea Manni, Sharlene Washington, James W. Griffith, Michael F. Verderame, David Mauger, Laurence M. Demers, Rajeev S. Samant, Danny R. Welch

Cumulative influence of elastin peptides and plasminogen on matrix metalloproteinase activation and type I collagen invasion by HT-1080 fibrosarcoma cells

Eric Huet, Bertrand Brassart, Jean-Hubert Cauchard, Laurent Debelle, Philippe Birembaut, Jean Wallach, Herve Emonard, Myriam Polette, William Hornebeck

Morphometric analysis of liver macrophages in patients with colorectal liver metastasis

Shinichi Miyagawa, Shiro Miwa, Junpei Soeda, Akira Kobayashi, Seiji Kawasaki

Regulation of melanoma cell migration and invasion by laminin-5 and α3β1 integrin (VLA-3)

Tsutomu Tsuji, Yoko Kawada, Mieko Kai-Murozono, Shinya Komatsu, Seon Ae Han, Ken-ichi Takeuchi, Hiroto Mizushima, Kaoru Miyazaki, Tatsuro Irimura

Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions

Ben Davidson, Reuven Reich, Juri Kopolovic, Aasmund Berner, Jahn M. Nesland, Gunnar B. Kristensen, Claes G. Tropé, Magne Bryne, Bjørn Risberg, Gregg van de Putte, Iris Goldberg

Antiangiogenic and antimetastatic properties of Neovastat (Æ-941), an orally active extract derived from cartilage tissue

Éric Dupont, Pierre Falardeau, Shaker A. Mousa, Violetta Dimitriadou, Marie-Claude Pepin, Taiqi Wang, Moulay A. Alaoui-Jamali

Distinctive alterations of invasiveness, drug resistance and cell–cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant

Muriel Affoué dit Faute, Luc Laurent, Dominique Ploton, Marie-France Poupon, Jean-Claude Jardillier, Hélène Bobichon

Effects of taurolidine and octreotide on port site and liver metastasis after laparoscopy in an animal model of pancreatic cancer

F.A. Wenger, M. Kilian, C. Braumann, A. Neumann, J. Ridders, F.J. Peter, H. Guski, C.A. Jacobi

Resistance to apoptosis is increased during metastatic dissemination of colon cancer

L. Oliver, S. Cordel, I. Barbieux, M.T. LeCabellec, K. Meflah, M. Grégoire, F.M. Vallette

Expression of the thrombin receptor PAR-1 correlates with tumour cell differentiation of pancreatic adenocarcinoma in vitro

Claudia Rudroff, Stefan Seibold, Roland Kaufmann, Cecilia Cu Zetina, Kathrin Reise, Ute Schäfer, Annette Schneider, Michael Brockmann, Johannes Scheele, Edmund A.M. Neugebauer

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine